SONICMED Revolutionizes Neurosurgical Standards at AANS 2026: Pioneering Ultrasonic Excellence Across Global Markets

SAN ANTONIO, TEXAS – May 4, 2026 – SONICMED, a quality-focused global ultrasonic surgical specialist, delivered a landmark showcase at the 94th AANS Annual Scientific Meeting, the world’s top neurosurgery summit. Drawing over 3,000 neurosurgeons, hos

Core Product Excellence: Precision Redefined
Under the guiding principle “SONICMED: Ultrasonic Energy – Precision in Motion, Motion in Precision.” (Neural precision, Ultrosonic precision: elevating safety in minimally invasive neurosurgery), SONICMED showcased its full neurosurgical portfolio, emphasizing 30 years of neural-focused innovation, 100,000+ successful neurological surgeries, and 300+ expert endorsements.
Key highlights included:
● Ultrasonic Aspirator: Featuring exclusive tissue-selective technology, it protects fragile neural structures while removing lesions, reducing bleeding and ensuring a clear surgical field. Over 300 onsite neurosurgeons universally acknowledged its clinical advantages, with dozens of senior U.S. specialists stating it outperforms comparable competitive aspirators..
● Ultrasonic Bone Cutter: Optimized for cranial and spinal procedures, it delivers low vibration, minimal thermal spread, and micro-thin tips to safeguard critical nerves and vessels. Live demos demonstrated faster cutting speed and enhanced safety compared to industry standards, with Texas-based surgeons praising its “exceptional precision and reduced operational noise.”
● SONICMED Integrated Ultrasonic-Bipolar Energy Device (BUC2000): A dual-energy innovation combining cutting, dissection, and vessel sealing, it minimizes instrument swaps and supports open, endoscopic, and spinal minimally invasive surgeries—impressing Italian and Turkish partners with its versatility.

Global Leadership in Ultrasonic Energy Solutions
SONICMED’s participation underscored its mission: “Empowering surgeons as the world’s leading provider of ultrasonic energy solutions.” With 30 years of R&D and brand legacy, 10+ years of CE/FDA certifications, and over 100 proprietary patents, the company adheres to strict global quality standards and demonstrated cross-specialty expertise spanning neurosurgery, spine, hepatobiliary, urology, gastrointestinal, general surgery, and gynecology.

At AANS 2026, SONICMED solidified its global footprint:
● North America: Secured cooperation with U.S. distributors and Canadian channels, with 15–20 U.S. hospitals targeted for trials by 2026 year-end.
● Latin America: Mexican surgeons and distributors expressed strong procurement intent, while Argentine partners advanced toward framework agreements.
● Middle East/Europe: Dubai clients finalized prototype orders, and Turkish partners initiated discussions on regulatory pathways.

Strategic Momentum for Market Expansion
The event marked a pivotal step in SONICMED’s U.S. market strategy, anchored by FDA compliance autonomy and a “device placement + extended warranty” model to navigate hospital procurement constraints. With plans to establish local teams and logistics hubs by 2027, SONICMED is poised to capture 8–12 U.S. hospital partnerships in 2026, accelerating toward 2028 sales targets of $20.5 million across ultrasonic bone cutters, aspirators, and beyond.

SONICMED: Where innovation meets precision—transforming neurosurgery, one ultrasonic breakthrough at a time.